AI’s immediate impact on driving revenue will likely take place in the Ambulatory Surgery Centers (ASC's) environment.
ASC’s by design and intention are for the low to mid-acuity cases, and positioned to have the opportunity to take advantage of higher volumes.
The profits and patient experience are in all of the points of engagement with patients, payers, surgeons, care teams, and administration.
ASC’s have less bureaucracy, provide a true causal evidence-based environment, and if selected appropriately a different psychographic of each team member.
Incorporating AI-driven platforms will result in more technology and implants sold, more fulfilled team members of the ASC, delighted payers and most importantly, the patient.
Joe Mullings, Holly Scott, and Tom Salemi set the stage for #DeviceTalksBoston in a recent conversation.
Watch now.
So that then started to say, OK, we can run these. ASC's but the issue with ASC's outside of ortho. Was you were still trying to run it as a remote hospital? And what is becoming very clear of the staffing issues happening in the ASC's right now, that is their number one issue out of all the ASC's. 45% of the surveyed ASC owners were staffing, staffing, staffing. I can't find staffing, predictive staffing or skilled staffing. So if you don't have the staffing in there to run those, you could no longer run your procedures through at a high enough volume for their them to be profitable. So what what we see happening. Is it's like hiring a person in a startup versus hiring a person in a large corporation. There are two different psychographics, right? The startup person enjoys that high agility change, high volume activity where again, I'm generalizing here where the hospital is. I'm getting into 9, leaving at 5. I'm punching my card. I'm just doing enough. And my success is not tied to the revenue of the hospital directly. We're in the ASC's. They are. So the device companies that are going to do well in the ASCs are going to address preop, intraop and postop activities, efficiencies, turn times, actionable data on the administrative economic side, not necessarily the clinical side. The ability to manage that patient all the way through, they're usually run by private equity. Private equity has a bunch of Harvard MBA's and Yale MBA's and right, who watched the numbers and track track track doesn't happen as much in the hospital. So the Med device companies that are moving into the hospitals right now and you mentioned in an earlier set striker. And Zimmer is also doing it. They are focusing on how are we partnering with you. And how are we helping you push those cases through, not just talking about clinical evidence, How do we become an efficiency partner to you, umm, and a data provider to you that you could run your dashboards financially, administratively, clinically, care team wise that you can prove there's efficiencies there and that's where you're going to have that. Evidence based partnership with the Med tech companies. You're not going to be able to hide in like you can in the hospital.
Bringing active solutions to spinal robotics— Vista Robotics - the innovative spinal robotic system for screw placements, automatic discectomy and endplate preparation, and interbody insertion to achieve sagittal balance
Joe Mullings Joe, I have said this multiple times that the next big phase of the ASCs for same day surgery is the ultra minimally invasive laminectomy surgery called unilateral biportal endoscopic (UBE) surgeries. Less than 5% of the USA surgeons are doing this today. Once surgeons are trained, these will be super huge for 500,000 of the cases in the USA that are performed with open laminectomy procedures at the hospital settings.
Bringing active solutions to spinal robotics— Vista Robotics - the innovative spinal robotic system for screw placements, automatic discectomy and endplate preparation, and interbody insertion to achieve sagittal balance
4dJoe Mullings Joe, I have said this multiple times that the next big phase of the ASCs for same day surgery is the ultra minimally invasive laminectomy surgery called unilateral biportal endoscopic (UBE) surgeries. Less than 5% of the USA surgeons are doing this today. Once surgeons are trained, these will be super huge for 500,000 of the cases in the USA that are performed with open laminectomy procedures at the hospital settings.